Navigation Links
InSightec is inviting ASTRO 2014 attendees to learn about its Oncology MR-guided Focused Ultrasound solution for alleviating pain caused by bone mets

HAIFA, Israel, Sept. 12, 2014 /PRNewswire/ -- InSightec, a world leader in MR-guided Focused Ultrasound (MRgFUS) will be on site at the ASTRO 56th annual meeting to present its MR-guided Focused Ultrasound solution for alleviating pain caused by bone mets.

ASTRO's annual meeting is the premier radiation oncology scientific event in the world, attracting more than 11,000 attendees each year. The 2014 meeting will look specifically at how scientific innovations combine technology and biology to advance cancer treatments, as well as improve patient outcomes and quality of life. 

InSightec believes that MRgFUS is a technology that is revolutionizing medicine as we know it. Therefore, it will present at the event its highly innovative MR-guided Focused Ultrasound solution for alleviating pain caused by painful bone metastases. 

This treatment option offers several strong advantages that make more and more patients as well as Radiation Oncologists consider it as a new, solid and effective alternative solution for treating pain caused by bone metastases. One of the most appealing advantages being that it requires no stoppage of planned or ongoing chemotherapy and therefore provides leverage for patient management.

It also allows for real-time feedback, so there are no surprises at the end of the procedure and patients enjoy immediate pain alleviation. Clinical evidence shows high success rates as well as a high safety profile. All these clear advantages drove leading physicians in prominent medical facilities around the world to adopt InSightec's Oncology offering. 

Today, researchers around the world are utilizing InSightec's technology to treat liver cancer, pancreatic cancer, prostate cancer, and breast cancer. 

InSightec's technology is currently FDA approved to treat bone metastases, and uterine fibroids. Treatment of additional indications is expected in the near future.  

We invite you to visit InSightec at the GE booth # 2228 to learn more about our unique non-invasive technology for treating cancer.

Note to editors


INSIGHTEC is a world leader in MR-guided Focused Ultrasound (MRgFUS). The company, founded in 1999, has developed a completely non-invasive therapy platform that transforms medicine in an expanding number of neurosurgery, oncology and gynecology indications. MRgFUS is already adopted and used by world recognized physicians in more than 120 leading medical facilities around the world, who see the tremendous clinical and economical value of the InSightec therapy platform.

The company has received numerous awards for innovation from well-respected organizations including the Wall Street Journal, the European Union and TIME Magazine. The company is privately held by GE Healthcare, Elbit Imaging, York Capital Management and MediTech Advisors. For more information please visit:

Media Contact

Xen Mendelsohn Aderka
VP of Marketing

SOURCE InSightec
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. InSightecs ExAblate technology was selected as one of CIRSE 2014s hot topics of the year
2. Elbit Imaging Ltd. Announces InSightecs ExAblate Neuro System Awarded European CE Mark for Non-invasive Treatment of Neurological Disorders in the Brain
3. CIVCO Unveils New Innovation Suite Showcasing the Broadest Portfolio of Patient Positioning and Immobilization Solutions at ASTRO 2014
4. Varian Treatment Planning Support for Siemens Modulated Arc (mARC) Treatments to be Highlighted at 2014 ASTRO Meeting in San Francisco
5. iCAD to Showcase its Comprehensive Electronic Brachytherapy Solutions and Services at 56th Annual American Society for Therapeutic Radiology and Oncology (ASTRO) Meeting
6. Elekta introduces Information-guided cancer care, highlighting Knowledge Management, at ASTRO 2014
7. Varian Medical Systems ASTRO Exhibit Spotlights Technology and Software that Support Knowledge Sharing Among Oncology Professionals
8. KemPharm, Inc. Advances KP201 Clinical Program with Initiation of Human Abuse Liability and Human Gastrointestinal Motility Trials
9. Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents
10. Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers
11. Japan Esophagoscopes & Gastroscopes Market Outlook to 2020
Post Your Comments:
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the ... a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, ... retirement havens have extremely low property-tax rates, which contributes to the relatively lower ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... and other leading institutions in announcing the launch of the Leadership Circle ... way animals are raised for food. , Founding members of the Leadership Circle ...
(Date:10/12/2017)... ... October 12, 2017 , ... Nvision Biomedical Technologies ... with the addition of industry sales leader, Thomas (Tom) Slott, as Senior Vice ... distribution and sales network, direct the efforts of the surgical sales teams, manage ...
Breaking Medicine News(10 mins):